Skip to main content
Veterinary Medicines

Covexin 10 Suspension for injection for sheep and cattle

Authorised
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium haemolyticum, toxoid
  • Clostridium sordellii, toxoid
  • Tetanus toxoid adsorbed
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium chauvoei, Inactivated

Product identification

Medicine name:
Covexin 10 Suspension for injection for sheep and cattle
Covexin 10 suspenzija za injiciranje za ovce in govedo
Active substance:
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium haemolyticum, toxoid
  • Clostridium sordellii, toxoid
  • Tetanus toxoid adsorbed
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium chauvoei, Inactivated
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type A, alpha toxoid
    0.90
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium haemolyticum, toxoid
    16.50
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium sordellii, toxoid
    0.80
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Tetanus toxoid adsorbed
    2.50
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    3.60
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium novyi, toxoid
    1.20
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.10
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B and C, beta toxoid
    12.40
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    90.00
    percentage protection
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI04AB01
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • (ID 2): 1 Box with 1 vial with 100 millilitres (50 vaccine doses)
  • (ID 1): 1 Box with 1 vial with 50 millilitres (25 vaccine doses)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
  • Schering-Plough Limited
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • MR/V/0076/001
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0283/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 26/03/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 26/03/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 26/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."